Shenming Wang Selected Research

Arteriosclerosis Obliterans

12/2020	Antisense long non‑coding RNA WEE2‑AS1 regulates human vascular endothelial cell viability via cell cycle G2/M transition in arteriosclerosis obliterans.
1/2020	TIM‑3 inhibits PDGF‑BB‑induced atherogenic responses in human artery vascular smooth muscle cells.
9/2015	MicroRNA-1298 is regulated by DNA methylation and affects vascular smooth muscle cell function by targeting connexin 43.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shenming Wang Research Topics

Disease

20	Breast Neoplasms (Breast Cancer) 09/2021 - 03/2008
20	Neoplasms (Cancer) 01/2019 - 09/2002
7	Atherosclerosis 01/2022 - 08/2012
5	Ischemia 01/2022 - 01/2012
5	Neoplasm Metastasis (Metastasis) 12/2021 - 08/2015
4	Wounds and Injuries (Trauma) 01/2019 - 01/2015
3	Aortic Dissection 06/2022 - 01/2013
3	Abdominal Aortic Aneurysm 05/2022 - 01/2013
3	Thyroid Neoplasms (Thyroid Cancer) 12/2021 - 01/2014
3	Venous Thrombosis (Deep-Vein Thrombosis) 01/2021 - 03/2011
3	Arteriosclerosis Obliterans 12/2020 - 09/2015
3	Varicose Veins (Varicose Vein) 12/2020 - 11/2009
3	False Aneurysm (Pseudoaneurysm) 01/2020 - 06/2013
3	Triple Negative Breast Neoplasms 01/2019 - 01/2014
3	Inflammation (Inflammations) 01/2018 - 08/2012
2	Infections 05/2022 - 01/2019
2	Chronic Limb-Threatening Ischemia 01/2021 - 01/2019
2	Aortic Diseases 01/2020 - 01/2013
2	Peripheral Arterial Disease 11/2019 - 04/2015
2	Papillary Thyroid Cancer 01/2018 - 05/2013
2	Endoleak 11/2015 - 07/2008
2	Thrombosis (Thrombus) 11/2015 - 03/2011
2	Carcinogenesis 01/2014 - 05/2013
2	Follicular Adenocarcinoma 02/2004 - 09/2002
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Coronary Disease (Coronary Heart Disease) 01/2021
1	Pathologic Processes 12/2020
1	Aortic Aneurysm (Aneurysm, Aortic) 01/2020
1	Paraganglioma (Paragangliomas) 06/2019
1	Dyslipidemias (Dyslipidemia) 04/2019
1	Body Weight (Weight, Body) 04/2019
1	Weight Gain 04/2019
1	Gestational Diabetes (Gestational Diabetes Mellitus) 03/2019
1	Hypothyroidism 03/2019
1	Hyperglycemia 03/2019
1	Thyroid Diseases (Thyroid Disease) 03/2019
1	Hypoxia (Hypoxemia) 01/2019
1	Carcinoma (Carcinomatosis) 01/2019
1	Hyperoxia 01/2019
1	Nasopharyngitis 08/2018
1	Musculoskeletal Pain 08/2018
1	Hyperlipidemias (Hyperlipidemia) 08/2018
1	Headache (Headaches) 08/2018

Drug/Important Bio-Agent (IBA)

9	MicroRNAs (MicroRNA)IBA 01/2022 - 05/2013
9	Proteins (Proteins, Gene)FDA Link 12/2020 - 09/2010
5	Small Interfering RNA (siRNA)IBA 12/2016 - 01/2013
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2013 - 09/2002
4	Biomarkers (Surrogate Marker)IBA 09/2021 - 02/2016
4	Estrogen ReceptorsIBA 09/2021 - 07/2015
4	Pharmaceutical PreparationsIBA 01/2021 - 09/2014
3	Tamoxifen FDA LinkGeneric 09/2021 - 09/2014
3	ParaffinIBA 06/2019 - 02/2016
3	Messenger RNA (mRNA)IBA 01/2018 - 12/2002
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2021 - 01/2016
2	LDL CholesterolIBA 04/2019 - 08/2018
2	Grape Seed ProanthocyanidinsIBA 04/2019 - 03/2011
2	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 03/2019 - 01/2014
2	InflammasomesIBA 10/2018 - 08/2012
2	Apolipoproteins E (ApoE)IBA 10/2018 - 03/2015
2	oxidized low density lipoproteinIBA 08/2018 - 08/2012
2	Interleukin-8 (Interleukin 8)IBA 08/2015 - 03/2008
2	IodineIBA 07/2015 - 08/2002
2	Thyroid HormonesIBA 01/2014 - 06/2002
2	Phosphates (Orthophosphate)IBA 09/2013 - 10/2007
2	DNA (Deoxyribonucleic Acid)IBA 12/2011 - 02/2011
2	RacivirIBA 02/2004 - 09/2002
1	Circular RNAIBA 01/2022
1	NF-kappa B (NF-kB)IBA 12/2021
1	NucleoproteinsIBA 12/2021
1	RNA (Ribonucleic Acid)IBA 12/2020
1	Antisense RNA (Anti-Sense RNA)IBA 12/2020
1	Long Noncoding RNAIBA 12/2020
1	Biological ProductsIBA 12/2020
1	SolutionsIBA 01/2020
1	Triglycerides (Triacylglycerol)IBA 04/2019
1	CholesterolIBA 04/2019
1	LipidsIBA 04/2019
1	HDL CholesterolIBA 04/2019
1	Oxygen (Dioxygen)IBA 01/2019
1	B7-H1 AntigenIBA 01/2019
1	LuciferasesIBA 10/2018
1	HMGB1 Protein (HMG1)IBA 10/2018
1	Glycyrrhizic Acid (Glycyrrhizin)IBA 10/2018
1	Receptor for Advanced Glycation End ProductsIBA 10/2018
1	HMGB ProteinsIBA 10/2018
1	NLR ProteinsIBA 10/2018
1	Liver X ReceptorsIBA 10/2018
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 10/2018
1	ALN-PCSIBA 08/2018
1	C-Reactive ProteinIBA 08/2018
1	Becaplermin (PDGF-BB)FDA Link 01/2018
1	Indicators and Reagents (Reagents)IBA 01/2018

Therapy/Procedure

13	Therapeutics 09/2021 - 06/2002
9	Stents 05/2022 - 07/2008
3	Endovascular Aneurysm Repair 06/2022 - 04/2016
2	Ligation 01/2022 - 03/2011
1	Aftercare (After-Treatment) 01/2021
1	Vascular Surgical Procedures 01/2019
1	Surgical Amputation (Amputations) 01/2019
1	Heterologous Transplantation (Xenotransplantation) 10/2018